Investors with a lot of money to spend have taken a bearish stance on AstraZeneca AZN.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with AZN, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 9 options trades for AstraZeneca.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 66%, bearish.
Out of all of the options we uncovered, 8 are puts, for a total amount of $1,434,134, and there was 1 call, for a total amount of $99,000.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $61.0 to $67.0 for AstraZeneca during the past quarter.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AstraZeneca's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AstraZeneca's whale trades within a strike price range from $61.0 to $67.0 in the last 30 days.
AstraZeneca Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| AZN | PUT | TRADE | BULLISH | 02/09/24 | $67.00 | $1.0M | 7.4K | 6.5K |
| AZN | CALL | TRADE | BULLISH | 01/16/26 | $65.00 | $99.0K | 101 | 0 |
| AZN | PUT | SWEEP | BULLISH | 02/09/24 | $67.00 | $97.6K | 7.4K | 7.0K |
| AZN | PUT | SWEEP | NEUTRAL | 02/16/24 | $65.00 | $61.7K | 1.2K | 12 |
| AZN | PUT | SWEEP | BEARISH | 02/09/24 | $67.00 | $50.6K | 7.4K | 848 |
About AstraZeneca
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
In light of the recent options history for AstraZeneca, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of AstraZeneca
- Currently trading with a volume of 3,534,555, the AZN's price is down by -1.8%, now at $66.06.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 22 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AstraZeneca options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
